These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7923211)

  • 1. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
    Adesina AM; Nalbantoglu J; Cavenee WK
    Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent p53 gene mutations in medulloblastomas.
    Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
    Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB; Bandea C; Swan D; Abbott K; Varma VA
    Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ; Jhanwar SC; Novick S; Pellicer A
    Cancer Res; 1991 Oct; 51(19):5410-6. PubMed ID: 1913660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
    Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
    Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity and p53 polymorphism Pro72Arg in a young patient with medulloblastoma.
    Sardi I; Giunti L; Donati P; Lacitignola L; Tucci F; Sardo L; Giovannucci Uzielli ML; Bernini G
    Oncol Rep; 2003; 10(3):773-5. PubMed ID: 12684657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of p53 gene mutations in primary neuroblastomas.
    Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
    Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the p53 gene in myelodysplastic syndromes.
    Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
    Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
    Vorechovský I; Tingby O; Hartman M; Strömberg B; Nister M; Collins VP; Toftgård R
    Oncogene; 1997 Jul; 15(3):361-6. PubMed ID: 9233770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
    Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13.
    Pietsch T; Koch A; Wiestler OD
    Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the p53 gene are not detectable in human testicular tumors.
    Fleischhacker M; Strohmeyer T; Imai Y; Slamon DJ; Koeffler HP
    Mod Pathol; 1994 May; 7(4):435-9. PubMed ID: 8066072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.